drugset / Trial / NCT03109600
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)
RandomizedParallel-groupSingle-blindPrevention
Summary
This study is to assess the safety of Vi-DT vaccine in adults and children.
Timeline
- Start
- 2017-04-18
- Primary completion
- 2017-09-28
- Completion
- 2018-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Virus Vaccine | Vaccine | — | — |
| Comparator | Prevnar 13 | Vaccine | — | — |
| Comparator | Vi Polysaccharide Vaccine | Vaccine | 0.5 ml | — |
| Subject | Vi-DT | Vaccine | 0.5 ml | — |
Indications
No indication recorded.